blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1263784

EP1263784 - NOVEL HUMAN ULIP/CRMP PROTEIN AND USE THEREOF IN DIAGNOSIS AND TREATMENT OF CANCERS AND PARANEOPLASTIC NEUROLOGICAL SYNDROMES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.06.2007
Database last updated on 31.08.2024
Most recent event   Tooltip11.09.2009Lapse of the patent in a contracting state
New state(s): TR		published on 14.10.2009  [2009/42]
Applicant(s)For all designated states
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
101, rue de Tolbiac
75013 Paris / FR
[2006/30]
Former [2002/50]For all designated states
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
101, rue de Tolbiac
75013 Paris / FR
Inventor(s)01 / AGUERA, Michèle
33A, chemin des Petites Brosses
F-69300 Caluire / FR
02 / ANTOINE, Jean-Christophe
Fontannes
F-42600 Chalin Le Comtal / FR
03 / BELIN, Marie-Françoise
5, place Carnot
F-69002 Lyon / FR
04 / HONNORAT, Jérôme
9, impasse René
F-69500 Bron / FR
05 / ROGEMONT, Véronique
204, avenue Félix Faure
F-69003 Lyon / FR
 [2002/50]
Representative(s)Bernasconi, Jean Raymond, et al
Cabinet Lavoix 2, Place d'Estienne d'Orves
75441 Paris Cedex 09 / FR
[N/P]
Former [2008/33]Bernasconi, Jean Raymond, et al
Cabinet Lavoix 2, Place d'Estienne d'Orves
75441 Paris Cedex 09 / FR
Former [2002/50]Bernasconi, Jean Raymond, et al
c/o Cabinet Lavoix, 2, Place d'Estienne d'Orves
75441 Paris Cedex 09 / FR
Application number, filing date01911811.628.02.2001
[2002/50]
WO2001FR00589
Priority number, dateFR2000000256629.02.2000         Original published format: FR 0002566
FR2000000500518.04.2000         Original published format: FR 0005005
[2002/50]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO0164737
Date:07.09.2001
Language:FR
[2001/36]
Type: A1 Application with search report 
No.:EP1263784
Date:11.12.2002
Language:FR
The application published by WIPO in one of the EPO official languages on 07.09.2001 takes the place of the publication of the European patent application.
[2002/50]
Type: B1 Patent specification 
No.:EP1263784
Date:26.07.2006
Language:FR
[2006/30]
Search report(s)International search report - published on:EP07.09.2001
ClassificationIPC:C07K14/47, C12N15/12, C12N5/10, C07K16/18, A61K38/17, A61K48/00, A61K39/395
[2002/50]
CPC:
C07K14/47 (EP,US); A61P25/00 (EP); A61P35/00 (EP);
A61P43/00 (EP); C07K14/435 (US); C07K14/4713 (US);
C07K14/4748 (US); C07K14/705 (US); C07K16/18 (US);
G01N33/6854 (US); A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/50]
TitleGerman:NEUES MENSCHLICHES ULIP/CRMP PROTEIN UND SEINE VERWENDUNG ZUR DIAGNOSE ZUR BEHANDLUNG VON KREBS UND VON NEUROLOGISCHEN PARANEOPLASTISCHEN SYNDROMEN[2002/50]
English:NOVEL HUMAN ULIP/CRMP PROTEIN AND USE THEREOF IN DIAGNOSIS AND TREATMENT OF CANCERS AND PARANEOPLASTIC NEUROLOGICAL SYNDROMES[2002/50]
French:NOUVELLE PROTEINE ULIP/CRMP HUMAINE ET SON UTILISATION DANS LE DIAGNOSTIC ET LA THERAPIE DES CANCERS ET DES SYNDROMES NEUROLOGIQUES PARANEOPLASIQUES[2002/50]
Entry into regional phase22.08.2002National basic fee paid 
22.08.2002Designation fee(s) paid 
22.08.2002Examination fee paid 
Examination procedure09.08.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.08.2002Examination requested  [2002/50]
13.02.2006Communication of intention to grant the patent
08.06.2006Fee for grant paid
08.06.2006Fee for publishing/printing paid
Opposition(s)27.04.2007No opposition filed within time limit [2007/27]
Fees paidRenewal fee
22.08.2002Renewal fee patent year 03
16.02.2004Renewal fee patent year 04
16.02.2005Renewal fee patent year 05
15.02.2006Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT26.07.2006
CY26.07.2006
FI26.07.2006
NL26.07.2006
TR26.07.2006
DK26.10.2006
SE26.10.2006
GR27.10.2006
PT26.12.2006
LU28.02.2007
MC28.02.2007
[2009/42]
Former [2009/37]AT26.07.2006
CY26.07.2006
FI26.07.2006
NL26.07.2006
DK26.10.2006
SE26.10.2006
GR27.10.2006
PT26.12.2006
LU28.02.2007
MC28.02.2007
Former [2008/19]AT26.07.2006
FI26.07.2006
NL26.07.2006
DK26.10.2006
SE26.10.2006
GR27.10.2006
PT26.12.2006
MC28.02.2007
Former [2008/04]AT26.07.2006
FI26.07.2006
NL26.07.2006
DK26.10.2006
SE26.10.2006
PT26.12.2006
MC28.02.2007
Former [2007/48]AT26.07.2006
FI26.07.2006
IT26.07.2006
NL26.07.2006
DK26.10.2006
SE26.10.2006
PT26.12.2006
MC28.02.2007
Former [2007/36]AT26.07.2006
FI26.07.2006
IT26.07.2006
NL26.07.2006
DK26.10.2006
SE26.10.2006
PT26.12.2006
Former [2007/23]AT26.07.2006
FI26.07.2006
NL26.07.2006
DK26.10.2006
SE26.10.2006
PT26.12.2006
Former [2007/22]FI26.07.2006
NL26.07.2006
DK26.10.2006
SE26.10.2006
PT26.12.2006
Former [2007/19]FI26.07.2006
NL26.07.2006
SE26.10.2006
PT26.12.2006
Former [2007/12]FI26.07.2006
SE26.10.2006
PT26.12.2006
Former [2007/10]FI26.07.2006
SE26.10.2006
Cited inInternational search[Y]FR2759701  (INST NAT SANTE RECH MED [FR]) [Y] 9,11,12,14 * page 12, line 14 - page 13, line 11 * * page 14, line 4 - line 19 * * page 15, line 15 - line 27 * * claims 5-17 *;
 [XY]  - YANAGI, S. ET AL., "Rattus norvegicus mRNA for dihydropyrimidinase-related protein, complete cds.", GENEMBL, (20000119), XP002157134 [X] 1,2,5-7,10,13,14 * Accession AB029432 * [Y] 9,11,12,14
    [ ] - INATOME ET AL., "Identification of CRAM, a novel unc-33 gene family protein that associates with CRMP3 and protein-tyrosine kinase(s) in the developing rat brain", J.BIOL.CHEM, (20000901), vol. 275, no. 35, pages 27291 - 27302, XP002157142 [ ] * the whole document *
 [X]  - HILLIER ET AL., "au56c05.y1 Scheneider fetal brain 0004 Homo sapiens cDNA clone IMAGE:2518760 5' similar to SW:DPY3_HUMAN Q14195 dihydropirimidinase related protein-3, mRNA sequence", GENEMBL, (19990722), XP002157135 [X] 4 * Accession AI879238 *
 [A]  - HILLIER ET AL., "au56c05.x1 Schneider fetal brain 00004 Homo sapiens cDNA clone IMAGE:2518760 3', mRNA sequence", GENEMBL, (19990722), XP002157136 [A] 4 * Accession AI879621 *
 [PX]  - FUKADA, M. ET AL., "Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family", J.BIOL.CHEM, (20001201), vol. 275, no. 48, pages 37957 - 37965, XP002157133 [PX] 1,2,5-7,10,13 * figure 1 *

DOI:   http://dx.doi.org/10.1074/jbc.M003277200
 [PX]  - HORIUCHI,M., "Homo sapiens mRNA for hypothetical protein (ORF1)", GENEMBL, (20000621), XP002157137 [PX] 1,2,5-7,10,13 * Accession AJ251275 *
    [ ] - HORIUCHI ET AL., "Ulip6, a novel unc-33 and dihydropyrimidinase related protein highly expressed in developing rat brain", FEBS LETTERS, (20000901), vol. 480, no. 2-3, pages 283 - 286, XP000961794

DOI:   http://dx.doi.org/10.1016/S0014-5793(00)01952-9
 [PX]  - YU, Z. ET AL., "Homo sapiens collapsin response mediator protein-5 (CRMP5) mRNA; complete cds.", GENEMBL, (20000706), XP002157138 [PX] 1,2,5-7,10,13 * Accession AF157634 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.